Glassbeam raises $10 million for data and predictive analytics platform, expanding into smart hospital ecosystem
Press releases may be edited for formatting or style
| December 14, 2021
SANTA CLARA, Calif., Dec. 14, 2021 /PRNewswire/ -- Glassbeam, Inc., a pioneer in machine data analytics for connected medical equipment, today announced that it raised $10M in a Series B funding led by Appian Way Asset Management, along with a strategic investment from one of its flagship healthcare accounts, MultiCare Health System. The proceeds of this financing will be used to scale up global commercial infrastructure including sales and marketing and product and customer success in order to meet the demands of the multi-billion dollar connected medical machine market. In addition, the company will utilize proceeds to refine and expand its offering to include additional analytical capabilities sought by the market.
The healthcare industry is undergoing a strategic shift from fee to value-based care, forcing providers to transform several areas related to medical equipment uptime and utilization. Efficiency and effectiveness require data driven insights to manage processes for scheduling, optimizing patient workflows and maximizing the utilization of assets that are spread across large hospital systems in a centralized manner.
Powered by artificial intelligence and machine learning technologies, Glassbeam Clinsights™ provides proactive alerts, predictive notifications, prescriptive recommendations and other smart maintenance capabilities for clinical engineering departments. By implementing Glassbeam Clinsights™ to automate the collection and analysis of high volumes of complex data from multiple and diverse endpoints, organizations are in a better position to transform their healthcare operations, lowering operating expenses, increasing the efficacy of delivering care and delivering an attractive return on investment for clients.
"We are excited about our partnership with Appian Way and MultiCare and believe their expertise and networks with large integrated delivery networks can accelerate our penetration of the market," said co-founder and CEO Puneet Pandit. "There is strong demand for analytics, powered by accurate machine data, from healthcare executives who want to improve decision making that will benefit patients and their bottom line. This funding helps validate our technology, our approach and vision to position Glassbeam as an agent of change in the healthcare industry."
"Decisions are best made with accurate, actionable information. Glassbeam provides essential data to healthcare executives to help them manage all forms of medical equipment from their imaging departments to their diagnostic labs across their systems through a consolidated dashboard in a way that hasn't been possible to date. Stakeholders are now realizing the return from deploying Glassbeam software in their systems and the result has positioned Glassbeam for multi-year inflective growth," said Richard Pines, a Member of Glassbeam's board of directors appointed by Appian Way Asset Management. "We believe in and are excited to support Glassbeam's vision for a Smart hospital ecosystem built upon the data and predictive analytics produced by its patented software platform."
You Must Be Logged In To Post A Comment
Registration is Free and Easy.
Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace.